Biosettia Inc is a firm focusing on the development and commercialization of molecular biology products and services to provide better solutions for life science research. The company strives to provide innovative tools and specialty reagents to aid in genome-wide functional analysis and generation of induced pluripotent stem cells (iPSC). These include single-strand RNAi technology, microRNA expression systems, normalized full-length cDNA libraries and lentiviral delivery systems.
Biosettia specializes in gene silencing by shRNA vector system, gene suppression by lentiviral miRNA, functionality screens by lentiviral miRNA, lentivirus production, lentiviral gene expression, and induced pluripotent stem cell generation and nucleic acid purification. By using a highly efficient lentiviral system, Biosettia has assisted many academic institutes, biotech and pharmaceutical companies in doing gene expression & inhibition-related studies.
In addition to providing reagents and services to academic institutes, biotech and pharmaceutical companies the firm has extended their research and development efforts to the fields of stem cell research, identification of cancer biomarkers, and discovery of next generation drug targets.
